Your browser doesn't support javascript.
loading
Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity.
Corbin, John A; Bhaskar, Vinay; Goldfine, Ira D; Bedinger, Daniel H; Lau, Angela; Michelson, Kristen; Gross, Lisa M; Maddux, Betty A; Kuan, Hua F; Tran, Catarina; Lao, Llewelyn; Handa, Masahisa; Watson, Susan R; Narasimha, Ajay J; Zhu, Shirley; Levy, Raphael; Webster, Lynn; Wijesuriya, Sujeewa D; Liu, Naichi; Wu, Xiaorong; Chemla-Vogel, David; Lee, Steve R; Wong, Steve; Wilcock, Diane; White, Mark L.
Afiliação
  • Corbin JA; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Bhaskar V; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Goldfine ID; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Bedinger DH; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Lau A; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Michelson K; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Gross LM; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Maddux BA; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Kuan HF; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Tran C; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Lao L; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Handa M; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Watson SR; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Narasimha AJ; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Zhu S; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Levy R; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Webster L; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Wijesuriya SD; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Liu N; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Wu X; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Chemla-Vogel D; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Lee SR; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Wong S; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • Wilcock D; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
  • White ML; Department of Preclinical Research, XOMA Corporation, Berkeley, California, United States of America.
PLoS One ; 9(2): e88684, 2014.
Article em En | MEDLINE | ID: mdl-24533136
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Insulina / Antígenos CD / Glucose / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Insulina / Antígenos CD / Glucose / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article